Philipp Heller joined Evonik in 2020 and is currently a project manager of innovation for the Health Care business line. In this role, he manages R&D and product development projects on parenteral drug delivery with a specific focus on lipid-based and polymeric drug delivery. Prior to his current role, Philipp worked as a research scientist at the German company BioNTech, where he was responsible for the development of lipid and polymer-based parenteral formulations for the delivery of mRNA therapeutics. Philipp holds a diploma in biomedical chemistry and a Ph.D. in polymer chemistry from the University of Mainz in Germany. He has contributed to numerous scientific publications and conferences.